|
DHX9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.17439999999192E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.77061999999673E-05 |
| Normal-vs-Stage2 |
5.194300E-04 |
| Normal-vs-Stage3 |
1.911780E-01 |
| Normal-vs-Stage4 |
1.216270E-02 |
| Stage1-vs-Stage2 |
7.595400E-01 |
| Stage1-vs-Stage3 |
7.805500E-02 |
| Stage1-vs-Stage4 |
5.657600E-01 |
| Stage2-vs-Stage3 |
1.176960E-01 |
| Stage2-vs-Stage4 |
5.150800E-01 |
| Stage3-vs-Stage4 |
3.008400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.39550000000044E-05 |
| Normal-vs-AfricanAmerican |
7.048600E-04 |
| Normal-vs-Asian |
4.961900E-02 |
| Caucasian-vs-AfricanAmerican |
9.489000E-01 |
| Caucasian-vs-Asian |
9.995400E-01 |
| AfricanAmerican-vs-Asian |
9.800000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.25640000003813E-06 |
| Normal-vs-Female |
2.419000E-01 |
| Male-vs-Female |
9.425000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.160100E-03 |
| Normal-vs-Extreme_Weight |
2.35749999999424E-05 |
| Normal-vs-Obese |
1.296370E-02 |
| Normal-vs-Extreme_Obese |
8.45360000000239E-05 |
| Normal_Weight-vs-Extreme_Weight |
4.017600E-01 |
| Normal_Weight-vs-Obese |
5.412000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.412960E-01 |
| Extreme_Weight-vs-Obese |
1.020410E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.039200E-01 |
| Obese-vs-Extreme_Obese |
6.633900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.698000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.139900E-03 |
| Normal-vs-Age(61-80Yrs) |
1.24239999998998E-06 |
| Normal-vs-Age(81-100Yrs) |
7.964100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.941600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.964500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.756090E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.509800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.554370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.857600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.384200E-04 |
| Normal-VS-Type2 PRCC |
2.56799999998059E-06 |
| Normal-VS-KIRP CIMP |
9.113600E-01 |
| Normal-VS-Unclassified PRCC |
9.618000E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.702500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.090950E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.511000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.460300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.741760E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.591960E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.59710000002811E-06 |
| Normal-vs-N1 |
9.665200E-01 |
| Normal-vs-N2 |
7.893600E-02 |
| N0-vs-N1 |
4.457700E-03 |
| N0-vs-N2 |
6.132600E-01 |
| N1-vs-N2 |
3.181400E-01 |
|
|
